Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Related structures:
AlphaFold database: A4HZH9
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 161 | 165 | PF00656 | 0.591 |
CLV_NRD_NRD_1 | 11 | 13 | PF00675 | 0.584 |
CLV_NRD_NRD_1 | 130 | 132 | PF00675 | 0.541 |
CLV_NRD_NRD_1 | 25 | 27 | PF00675 | 0.486 |
CLV_NRD_NRD_1 | 66 | 68 | PF00675 | 0.455 |
CLV_PCSK_KEX2_1 | 121 | 123 | PF00082 | 0.599 |
CLV_PCSK_KEX2_1 | 130 | 132 | PF00082 | 0.517 |
CLV_PCSK_KEX2_1 | 27 | 29 | PF00082 | 0.591 |
CLV_PCSK_KEX2_1 | 55 | 57 | PF00082 | 0.535 |
CLV_PCSK_KEX2_1 | 68 | 70 | PF00082 | 0.406 |
CLV_PCSK_PC1ET2_1 | 121 | 123 | PF00082 | 0.599 |
CLV_PCSK_PC1ET2_1 | 27 | 29 | PF00082 | 0.591 |
CLV_PCSK_PC1ET2_1 | 55 | 57 | PF00082 | 0.535 |
CLV_PCSK_PC1ET2_1 | 68 | 70 | PF00082 | 0.406 |
CLV_PCSK_SKI1_1 | 121 | 125 | PF00082 | 0.629 |
CLV_PCSK_SKI1_1 | 151 | 155 | PF00082 | 0.643 |
CLV_PCSK_SKI1_1 | 31 | 35 | PF00082 | 0.624 |
DEG_APCC_DBOX_1 | 40 | 48 | PF00400 | 0.488 |
DOC_MAPK_gen_1 | 31 | 39 | PF00069 | 0.462 |
DOC_PP1_RVXF_1 | 29 | 36 | PF00149 | 0.624 |
DOC_PP2B_LxvP_1 | 123 | 126 | PF13499 | 0.667 |
DOC_PP4_FxxP_1 | 59 | 62 | PF00568 | 0.484 |
DOC_USP7_MATH_1 | 8 | 12 | PF00917 | 0.635 |
DOC_USP7_MATH_1 | 99 | 103 | PF00917 | 0.741 |
DOC_USP7_UBL2_3 | 13 | 17 | PF12436 | 0.705 |
DOC_USP7_UBL2_3 | 132 | 136 | PF12436 | 0.734 |
DOC_USP7_UBL2_3 | 27 | 31 | PF12436 | 0.528 |
DOC_WW_Pin1_4 | 87 | 92 | PF00397 | 0.775 |
DOC_WW_Pin1_4 | 93 | 98 | PF00397 | 0.769 |
LIG_Actin_WH2_2 | 40 | 57 | PF00022 | 0.603 |
LIG_BRCT_BRCA1_1 | 10 | 14 | PF00533 | 0.715 |
LIG_FHA_1 | 34 | 40 | PF00498 | 0.608 |
LIG_FHA_1 | 88 | 94 | PF00498 | 0.749 |
LIG_FHA_2 | 1 | 7 | PF00498 | 0.730 |
LIG_REV1ctd_RIR_1 | 107 | 116 | PF16727 | 0.643 |
LIG_SH3_4 | 132 | 139 | PF00018 | 0.651 |
LIG_TRAF2_1 | 86 | 89 | PF00917 | 0.713 |
LIG_WRC_WIRS_1 | 163 | 168 | PF05994 | 0.669 |
MOD_GSK3_1 | 162 | 169 | PF00069 | 0.672 |
MOD_GSK3_1 | 33 | 40 | PF00069 | 0.576 |
MOD_NEK2_1 | 166 | 171 | PF00069 | 0.667 |
MOD_NEK2_1 | 33 | 38 | PF00069 | 0.547 |
MOD_PKA_2 | 37 | 43 | PF00069 | 0.575 |
MOD_Plk_2-3 | 101 | 107 | PF00069 | 0.752 |
MOD_Plk_2-3 | 162 | 168 | PF00069 | 0.556 |
MOD_Plk_4 | 111 | 117 | PF00069 | 0.624 |
MOD_Plk_4 | 162 | 168 | PF00069 | 0.672 |
MOD_ProDKin_1 | 87 | 93 | PF00069 | 0.774 |
MOD_SUMO_for_1 | 47 | 50 | PF00179 | 0.374 |
MOD_SUMO_rev_2 | 118 | 123 | PF00179 | 0.691 |
MOD_SUMO_rev_2 | 77 | 86 | PF00179 | 0.684 |
TRG_DiLeu_BaEn_1 | 66 | 71 | PF01217 | 0.467 |
TRG_ER_diArg_1 | 129 | 131 | PF00400 | 0.520 |
TRG_ER_diArg_1 | 56 | 59 | PF00400 | 0.598 |
TRG_ER_diArg_1 | 67 | 70 | PF00400 | 0.436 |
TRG_Pf-PMV_PEXEL_1 | 58 | 63 | PF00026 | 0.574 |
TRG_Pf-PMV_PEXEL_1 | 73 | 77 | PF00026 | 0.377 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A1X0NH88 | Trypanosomatidae | 34% | 97% |
A0A3S7WWT3 | Leishmania donovani | 99% | 100% |
A0A422N8U7 | Trypanosoma rangeli | 34% | 98% |
A4HC37 | Leishmania braziliensis | 74% | 99% |
D0A0Y3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 82% |
E9AVG9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
Q4QC10 | Leishmania major | 88% | 100% |